Editas Medicine Inc.

NASDAQ: EDIT · Real-Time Price · USD
3.04
0.08 (2.70%)
At close: Aug 15, 2025, 3:59 PM
2.97
-2.30%
After-hours: Aug 15, 2025, 05:09 PM EDT

Editas Medicine Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
131.54M 123.65M 141.52M 203.52M
Short-Term Investments
138.37M 199.46M 202.75M 296.33M
Long-Term Investments
3.88M 104.02M 93.1M 120.07M
Other Long-Term Assets
1.35M 8.59M 5.25M 6.81M
Receivables
16.27M 10.19M 5.14M 267K
Inventory
n/a n/a -93.1M n/a
Other Current Assets
3.14M 7.53M 100.43M n/a
Total Current Assets
289.31M 340.83M 356.75M 507.31M
Property-Plant & Equipment
47.05M 45.71M 59.22M 43.29M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
52.27M 158.32M 157.57M 170.17M
Total Assets
341.59M 499.15M 514.32M 677.48M
Account Payables
5.49M 8.27M 9.51M 5.05M
Deferred Revenue
6.22M 8.22M 8.22M 11.33M
Short-Term Debt
14.65M 12M 11.08M 10.31M
Other Current Liabilities
36.21M -723K 10.07M -150K
Total Current Liabilities
77.22M 63.22M 60.11M 46.88M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
3.07M 1.8M n/a n/a
Total Long-Term Liabilities
130.09M 86.84M 93.53M 76.96M
Total Liabilities
207.31M 150.06M 153.64M 123.84M
Total Debt
35.03M 36.54M 43.95M 26.38M
Common Stock
8K 8K 7K 7K
Retained Earnings
-1.47B -1.23B -1.08B -857.7M
Comprehensive Income
268K 198K -3.6M -493K
Shareholders Equity
134.27M 349.1M 360.68M 553.64M
Total Investments
138.37M 303.48M 295.85M 416.4M